Results 91 to 100 of about 19,233 (248)

Long‐Term Durability of Transcatheter Aortic Valves in Patients With Bicuspid Aortic Stenosis

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Data concerning the long‐term durability of transcatheter aortic valves (TAVs) in patients with bicuspid aortic stenosis (AS) are lacking. Aims The study aims to report data on long‐term valve durability following transcatheter aortic valve replacement (TAVR) in bicuspid AS.
Yuheng Jia   +46 more
wiley   +1 more source

Prognostic value of the ratio between prothesis area and indexed annulus area measured by multiSlice-CT for transcatheter aortic valve implantation procedures [PDF]

open access: yes, 2016
Background Postprocedural aortic regurgitations following transcatheter aortic valve implantation (TAVI) procedures remain an is- sue. Benefit of oversizing strategies to prevent them isn’t well established.
Bical A   +8 more
core  

A new surgical approach for treating dilated cardiomyopathy with mitral regurgitation [PDF]

open access: yes, 2000
OBJECTIVE: To evaluate the early outcome of mitral valve prostheses implantation and left ventricular remodeling in 23 patients with end-stage cardiomyopathy and secondary mitral regurgitation (NYHA class III and IV).
Branco, João Nelson Rodrigues   +3 more
core   +1 more source

Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart Failure

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Comorbidities like a history of chronic obstructive pulmonary disease (COPD), atrial fibrillation (AF) and heart failure (HF) can cause similar symptoms as aortic stenosis (AS). However, how they influence symptom improvement and long‐term outcomes after transcatheter aortic valve implantation (TAVI) is unclear.
Kees H. van Bergeijk   +21 more
wiley   +1 more source

Transcatheter aortic valve implantation: predictors of procedural success—the Siegburg-Bern experience [PDF]

open access: yes, 2017
Aims The purpose of the present analysis was to identify predictors of procedural success of percutaneous transcatheter aortic valve implantation (TAVI). Methods and results We prospectively assessed in-hospital outcome of patients undergoing TAVI at two
Buellesfeld, Lutz   +9 more
core  

Triple Björk-Shiley valve: More than 30 years of asymptomatic functioning: To the memory of late academic Prof. Isidor Papo and the 45th anniversary of the first valve implantation in Yugoslavia [PDF]

open access: yes, 2010
Introduction. The Björk-Shiley Delrin (BSD) tilting disc heart valve was first clinically used in 1969. A triple BSD valve replacement has not been quite common, because of high postoperative risk and complications, but there have been several cases with
Krotin Mirjana   +2 more
core   +1 more source

Comparison of Latest Generation Intra‐ and Supra‐Annular Self‐Expanding Transcatheter Heart Valves for Aortic Valve‐in‐Valve Procedures

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Valve‐in‐valve (ViV) procedures are an established therapy. Self‐expanding (SE) supra‐annular transcatheter heart valves (THV) achieve superior hemodynamics compared to balloon‐expandable (BE) intra‐annular THV, but influence of stent design versus valve position remains unclear.
Antonia Katharina Stötzel   +9 more
wiley   +1 more source

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

open access: yes, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Bleiziffer, S   +13 more
core   +1 more source

Transcatheter Aortic Valve Implantation in a Ross Procedure Patient With Severe Autograft Regurgitation: A Case Report

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Surgical aortic valve replacement (AVR) is the standard treatment for symptomatic severe neo‐aortic regurgitation in Ross patients. The only previous report of a transcatheter aortic valve implantation (TAVI) in a Ross patient required valve‐in‐valve rescue. Thus, this is the first uncomplicated TAVI procedure in a Ross patient.
Anindya Mukherjee   +3 more
wiley   +1 more source

Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. [PDF]

open access: yes, 2014
IMPORTANCE: Owing to a considerable shift toward bioprosthesis implantation rather than mechanical valves, it is expected that patients will increasingly present with degenerated bioprostheses in the next few years.
Barbanti, M.   +38 more
core   +1 more source

Home - About - Disclaimer - Privacy